Green Cures Debt
GRCU Stock | USD 0.0001 0.0001 50.00% |
Green Cures Botanical holds a debt-to-equity ratio of 0.091. . Green Cures' financial risk is the risk to Green Cures stockholders that is caused by an increase in debt.
Asset vs Debt
Equity vs Debt
Green Cures' liquidity is one of the most fundamental aspects of both its future profitability and its ability to meet different types of ongoing financial obligations. Green Cures' cash, liquid assets, total liabilities, and shareholder equity can be utilized to evaluate how much leverage the Company is using to sustain its current operations. For traders, higher-leverage indicators usually imply a higher risk to shareholders. In addition, it helps Green Pink Sheet's retail investors understand whether an upcoming fall or rise in the market will negatively affect Green Cures' stakeholders.
For most companies, including Green Cures, marketable securities, inventories, and receivables are the most common assets that could be converted to cash. However, for Green Cures Botanical, the most critical issue when managing liquidity is ensuring that current assets are properly aligned with current liabilities. If they are not, Green Cures' management will need to obtain alternative financing to ensure there are always enough cash equivalents on the balance sheet to meet obligations.
Given that Green Cures' debt-to-equity ratio measures a Company's obligations relative to the value of its net assets, it is usually used by traders to estimate the extent to which Green Cures is acquiring new debt as a mechanism of leveraging its assets. A high debt-to-equity ratio is generally associated with increased risk, implying that it has been aggressive in financing its growth with debt. Another way to look at debt-to-equity ratios is to compare the overall debt load of Green Cures to its assets or equity, showing how much of the company assets belong to shareholders vs. creditors. If shareholders own more assets, Green Cures is said to be less leveraged. If creditors hold a majority of Green Cures' assets, the Company is said to be highly leveraged.
Green |
Green Cures Botanical Debt to Cash Allocation
Green Cures Botanical currently holds 3.1 M in liabilities with Debt to Equity (D/E) ratio of 0.09, which may suggest the company is not taking enough advantage from borrowing. Green Cures Botanical has a current ratio of 4.75, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Green Cures until it has trouble settling it off, either with new capital or with free cash flow. So, Green Cures' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Green Cures Botanical sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Green to invest in growth at high rates of return. When we think about Green Cures' use of debt, we should always consider it together with cash and equity.Green Cures Assets Financed by Debt
Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Green Cures' operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Green Cures, which in turn will lower the firm's financial flexibility.Green Cures Corporate Bonds Issued
Understaning Green Cures Use of Financial Leverage
Green Cures' financial leverage ratio measures its total debt position, including all of its outstanding liabilities, and compares it to Green Cures' current equity. If creditors own a majority of Green Cures' assets, the company is considered highly leveraged. Understanding the composition and structure of Green Cures' outstanding bonds gives an idea of how risky it is and if it is worth investing in.
Green Cures Botanical Distribution Inc. operates various services and products in the medical marijuana and botanical industry. Green Cures Botanical Distribution Inc. is based in Inglewood, California. Green Cures operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 20 people. Please read more on our technical analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Green Pink Sheet Analysis
When running Green Cures' price analysis, check to measure Green Cures' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Green Cures is operating at the current time. Most of Green Cures' value examination focuses on studying past and present price action to predict the probability of Green Cures' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Green Cures' price. Additionally, you may evaluate how the addition of Green Cures to your portfolios can decrease your overall portfolio volatility.
What is Financial Leverage?
Financial leverage is the use of borrowed money (debt) to finance the purchase of assets with the expectation that the income or capital gain from the new asset will exceed the cost of borrowing. In most cases, the debt provider will limit how much risk it is ready to take and indicate a limit on the extent of the leverage it will allow. In the case of asset-backed lending, the financial provider uses the assets as collateral until the borrower repays the loan. In the case of a cash flow loan, the general creditworthiness of the company is used to back the loan. The concept of leverage is common in the business world. It is mostly used to boost the returns on equity capital of a company, especially when the business is unable to increase its operating efficiency and returns on total investment. Because earnings on borrowing are higher than the interest payable on debt, the company's total earnings will increase, ultimately boosting stockholders' profits.Leverage and Capital Costs
The debt to equity ratio plays a role in the working average cost of capital (WACC). The overall interest on debt represents the break-even point that must be obtained to profitability in a given venture. Thus, WACC is essentially the average interest an organization owes on the capital it has borrowed for leverage. Let's say equity represents 60% of borrowed capital, and debt is 40%. This results in a financial leverage calculation of 40/60, or 0.6667. The organization owes 10% on all equity and 5% on all debt. That means that the weighted average cost of capital is (.4)(5) + (.6)(10) - or 8%. For every $10,000 borrowed, this organization will owe $800 in interest. Profit must be higher than 8% on the project to offset the cost of interest and justify this leverage.Benefits of Financial Leverage
Leverage provides the following benefits for companies:- Leverage is an essential tool a company's management can use to make the best financing and investment decisions.
- It provides a variety of financing sources by which the firm can achieve its target earnings.
- Leverage is also an essential technique in investing as it helps companies set a threshold for the expansion of business operations. For example, it can be used to recommend restrictions on business expansion once the projected return on additional investment is lower than the cost of debt.